Brian J. Czerniecki and Gary K. Koski of the School of Medicine are featured for their experimental vaccine to treat early-stage breast cancer.
Perelman School of Medicine
PHILADELPHIA –Researchers at the University of Pennsylvania School of Medicine’s Udall Center for Parkinson's Research have developed the first blood-based biomarker test to predict cognitive decline in Parkinson’s disease (PD). If results can be replicated and standardized in other Parkinson patients, by other investigators, the test could be a useful tool to use in selecting patients for the development of new drugs that can slow or prevent this complication of the disease.
Arthur Caplan of the School of Medicine weighs in on the discussion of presumed-consent policies for organ donations.
PHILADELPHIA - Mimicking the reflective iridescence of a butterfly's wing, investigators at the University of Pennsylvania School of Medicine and School of Engineering and Applied Sciences have developed a color-changing patch that could be worn on soldiers' helmets and uniforms to indicate the strength of exposure to blasts from explosives in the field.
Kathryn Schmitz of the School of Medicine discusses her research on the benefits of exercise for patients undergoing cancer treatments.
Caryn Lerner of the School of Medicine comments on how genetics may play a role in smoking cessation.
Arthur Caplan of the School of Medicine comments on the ethics of reneging on prior transplant approvals.